Independent Research Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €72.00 Price Target

Independent Research set a €72.00 ($83.72) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Friday. The brokerage currently has a neutral rating on the stock.

A number of other research firms have also recently weighed in on FME. Jefferies Financial Group set a €82.00 ($95.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Monday, October 1st. JPMorgan Chase & Co. set a €97.90 ($113.84) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, August 29th. Sanford C. Bernstein set a €107.00 ($124.42) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Monday, October 1st. Goldman Sachs Group set a €98.00 ($113.95) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Monday, October 1st. Finally, Deutsche Bank set a €107.00 ($124.42) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Friday, October 5th. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA presently has an average rating of Buy and an average target price of €87.36 ($101.59).

ETR:FME opened at €62.24 ($72.37) on Friday. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €75.53 ($87.83) and a 1-year high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Further Reading: How does inflation affect different investments?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply